Provider roles in the recruitment of underrepresented populations to cancer clinical trials

Providers play a vital role in the successful recruitment of underrepresented patients to cancer clinical trials because they often introduce the opportunity of clinical trials. The purpose of the current systematic review was to describe provider‐related factors influencing recruitment of underrepresented populations to cancer clinical trials.

[1]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[2]  J. Crawford,et al.  Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials , 2002, Cancer.

[3]  J. Bailar,et al.  Selection and description of cancer clinical trials participants—Science or happenstance? , 2002, Cancer.

[4]  K. Mooney,et al.  Factors that influence Spanish‐ and English‐speaking participants' decision to enroll in cancer randomized clinical trials , 2006, Psycho-oncology.

[5]  L. R. Fischer.  Mental Illness in Nursing Homes: Agenda for Research, Mary S. Harper, Barry Leibowitz (Eds.). National Institute of Mental Health, US Department of Health and Human Services, Rockville, MD (1986) , 1987 .

[6]  Sarah M. Greene,et al.  Organizational barriers to physician participation in cancer clinical trials. , 2005, The American journal of managed care.

[7]  E. Perez,et al.  Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  L. Finison,et al.  Medical oncologists' participation in cancer clinical trials. , 1984, Progress in clinical and biological research.

[9]  P. Philip,et al.  Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Young,et al.  Entry into clinical trials in breast cancer: the importance of specialist teams. Scottish Breast Cancer Focus Group and Scottish Cancer Therapy Network. , 1998, European journal of cancer.

[11]  W. McCaskill-Stevens,et al.  Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) Initiative. , 2000, Annals of epidemiology.

[12]  E. Emanuel,et al.  Are Racial and Ethnic Minorities Less Willing to Participate in Health Research? , 2005, PLoS medicine.

[13]  D. Gandara,et al.  Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  L. Beckett,et al.  An Evaluation of Barriers to Accrual in the Era of Legislation Requiring Insurance Coverage of Cancer Clinical Trial Costs in California , 2004, Cancer journal.

[15]  T. Ricketts,et al.  Clinical trial enrollment of rural patients with cancer. , 2002, Cancer practice.

[16]  V. Pinn,et al.  NIH Policy on the Inclusion of Women and Minorities as Subjects in Clinical Research , 2002 .

[17]  M. Christian,et al.  How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  A. Rademaker,et al.  Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  B. Given,et al.  To refer or not to refer: Factors that affect primary care provider referral of patients with cancer to clinical treatment trials. , 2004, Journal of cancer education : the official journal of the American Association for Cancer Education.

[20]  H. Rugo,et al.  Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers. , 2005, Clinical breast cancer.

[21]  W. McCaskill-Stevens,et al.  Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  H. Cohen,et al.  Barriers to clinical trial participation by older women with breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Tung T. Nguyen,et al.  Participation of Asian‐American women in cancer chemoprevention research , 2005, Cancer.

[24]  H. Cohen,et al.  Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  R. Souhami,et al.  Clinicians' attitudes to clinical trials of cancer therapy. , 1997, European journal of cancer.

[26]  J. Richardson,et al.  Participation of community medical oncologists in clinical research trials. , 1986, Progress in clinical and biological research.

[27]  A. Giuliano,et al.  Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. , 2005, American journal of surgery.